Acid sphingomyelinase as new treatment for Gaucher disease: the progress
The treatment of acid sphingomyelinase, the new treatment for Gaucher disease type 3 and the consensus on the management of Parkinson's disease risk in subjects with Gaucher disease. These are the main news at the center of the annual…